Keloid
Conditions
Interventions
Control Group:Local injection of compound betamethasone injection
Experimental Group:In addition to the control group, administer the oral formula for resolving nodules and removing scars.
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Meets the diagnostic criteria for keloid and the criteria for qi stagnation and blood stasis syndrome in traditional Chinese medicine; 2) Age between 18 and 65 years old; 3) No wounds at the scar site or wounds that have healed well and fully epithelialized for at least one month; 4) No local scar injections or other oral medications for scar treatment within the past three months; 5) Normal results from blood tests and liver and kidney function tests 6) Voluntarily participates in the study and signs the informed consent form
Exclusion criteria
Exclusion criteria: 1) Women who are pregnant, intending to become pregnant, or breastfeeding; 2) Individuals with abnormal blood tests, liver or kidney function, or those suffering from chronic liver or kidney diseases or other severe illnesses 3) Individuals with a highly sensitive constitution or allergies to any components of the known anti-scar formula; 4) Individuals who have undergone scar-related treatment within the past three months or are currently taking other medications; 5) Individuals with obvious mental symptoms who are unable to cooperate with treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficient; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS);Dermatology Life Quality Index (DLQI); | — |
Countries
China
Contacts
Public ContactYang Dingquan
China-Japan Friendship Hospital
Outcome results
None listed